Shandong Sinobioway Biomedicine Co Ltd (002581) — Cash Flow-to-Debt Ratio
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of CN¥-86.58 Million could theoretically repay 0% of its total liabilities (CN¥221.51 Million) in one year. Explore 002581 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Sinobioway Biomedicine Co Ltd Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Shandong Sinobioway Biomedicine Co Ltd across 18 annual periods. Also explore total assets of Shandong Sinobioway Biomedicine Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)
Year-by-year debt coverage analysis for Shandong Sinobioway Biomedicine Co Ltd. For market capitalisation and broader financial context, see Shandong Sinobioway Biomedicine Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | CN¥-6.55 Million | CN¥173.61 Million | ▲ +83.1% |
| 2023 | -0.22x | CN¥-36.51 Million | CN¥163.41 Million | ▼ -59.7% |
| 2022 | -0.14x | CN¥-54.49 Million | CN¥389.46 Million | ▲ +12.8% |
| 2021 | -0.16x | CN¥-46.02 Million | CN¥286.76 Million | ▼ -320.5% |
| 2020 | 0.07x | CN¥18.51 Million | CN¥254.33 Million | ▲ +54.1% |
| 2019 | 0.05x | CN¥48.41 Million | CN¥1.03 Billion | ▼ -6.5% |
| 2018 | 0.05x | CN¥74.46 Million | CN¥1.47 Billion | ▼ -79.9% |
| 2017 | 0.25x | CN¥271.11 Million | CN¥1.08 Billion | ▼ -76.2% |
| 2016 | 1.06x | CN¥169.32 Million | CN¥160.16 Million | ▲ +108.7% |
| 2015 | 0.51x | CN¥137.73 Million | CN¥271.92 Million | ▼ -87.3% |
| 2014 | 3.99x | CN¥80.11 Million | CN¥20.08 Million | ▲ +70.3% |
| 2013 | 2.34x | CN¥83.13 Million | CN¥35.49 Million | ▼ -8.5% |
| 2012 | 2.56x | CN¥63.04 Million | CN¥24.62 Million | ▼ -38.4% |
| 2011 | 4.15x | CN¥74.43 Million | CN¥17.91 Million | ▲ +56.7% |
| 2010 | 2.65x | CN¥85.71 Million | CN¥32.34 Million | ▲ +72.8% |
| 2009 | 1.53x | CN¥54.06 Million | CN¥35.24 Million | ▼ -10.3% |
| 2008 | 1.71x | CN¥46.89 Million | CN¥27.41 Million | ▼ -20.8% |
| 2007 | 2.16x | CN¥25.07 Million | CN¥11.60 Million | — |